Press Releases for ACUS

Press Releases
Acusphere, Inc. Announces Prepayment of Equipment Loans
Acusphere, Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results
Acusphere Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
Acusphere Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments
Acusphere Announces Publication of Imagify™ Phase 3 Trials in the European Journal of Echocardiography
Acusphere, Inc. Announces Receipt of NASDAQ Panel Decision to Delist Common Stock
Acusphere, Inc. Announces Resignation of Richard Walovitch
Acusphere Announces Results of FDA Advisory Committee Meeting
Acusphere, Inc.’s Stock Trading Halted Today; FDA Advisory Committee Meets to Discuss Imagify™
Acusphere, Inc. Announces Posting of Briefing Documents for FDA Cardio Renal Drugs Advisory Committee Meeting on Imagify™
Acusphere, Inc. Announces Resignation of Howard Bernstein
Acusphere Announces Data Demonstrating Imagify(TM) Perfusion Stress Echo Predicts Presence of Coronary Artery Disease
Acusphere, Inc. Reports Q3 2008 Financial Results and Business Highlights
Acusphere to Host Conference Call to Discuss Q3 2008 Results and Upcoming Events
Acusphere Announces Closing of Transaction with Cephalon
Acusphere Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market
Acusphere Announces Signing of a Definitive Agreement with Cephalon
Zacks Analyst Blog Highlights: Acusphere, Inc., KeyCorp, Electroglas, Inc., Amkor Technology, Inc. And Broadcom Corp.
Acusphere's Imagify(TM) to be Reviewed at FDA Advisory Committee Meeting on December 10, 2008
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
Acusphere Receives Letter from NASDAQ Citing Failure to Comply with the Minimum Stockholders' Equity Requirement
Acusphere, Inc. Reports Q2 2008 Financial Results and Business Highlights
Acusphere Announces Staff Reductions
Acusphere Receives Letter From NASDAQ Citing Failure to Regain Compliance With Minimum Bid Price Rules - Jul 15 2008 10:11AM
Acusphere Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rules - Jul 15 2008 9:01AM
BeaconEquity.com Issues TraderNotes on Active Stocks: XSNX, ASTM, IMB, ACUS, PWAV, OPWV, OPTV, LUNA
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Acusphere, Inc. Reschedules IP Payments - May 27 2008 12:58AM
Acusphere, Inc. Reports Q1 2008 Financial Results and Business Highlights - Jun 1 2008 6:30AM
Acusphere Submits New Drug Application for FDA Approval of Imagify(TM)